This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,514.70, is for the delivery of the "4566415286 ! ACP MAX PRP SYSTEM (W/ ACDA)" product. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and an Ultimate Completion Date of November 18, 2024. This contract award is not...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, by the Defense Logistics Agency (DLA). The contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic product. The fixed-price contract with economic price adjustment has a ceiling value of $1,514.70 and a period of performance through September 10, 2024. Arthrex, a for-profit Subchapter S Corporation based in Naples, Florida, has received...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,573.50 fixed-price delivery order is for the 4566485933 ACP MAX PRP SYSTEM (W/ ACDA), with a period of performance ending on November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a robust portfolio of orthopedic medical products, including surgical implants, arthroscopic...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, by the Defense Logistics Agency's Medical Supply Chain. The contract is a Delivery Order valued at $7,920.00 with a fixed price and economic price adjustment pricing type. The award is for the ACP MAX PRP SYSTEM (OUS/EU), a specialized medical device, with an ultimate completion date of April 16, 2025. This contract is not set-aside and is part of a larger Indefinite...
This federal contract award, with ID SPE2DE24DA017|SPE2D625F1Q9F, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $11,726.60, is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. It is not set aside for any specific business category. The contract is for the ACP MAX PRP SYSTEM (OUS/EU), which likely includes specialized...
This federal contract award, identified as SPE2DE24DA017|SPE2D625F2D2W, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a Delivery Order with a fixed price and economic price adjustment, valued at $1,163.58, and has an ultimate completion date of April 14, 2025. The contract covers the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized medical device used in...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,633.30, is a Delivery Order for an "ACP MAX PRP SYSTEM (W/ ACDA)" and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 9, 2025. The contract was not designated as a...
This federal contract award, identified as SPE2DE24DA017|SPE2D625F34YT, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $1,127.94 fixed-price with economic price adjustment delivery order contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic medical product. Arthrex, a for-profit Subchapter S Corporation, has demonstrated extensive capabilities...
This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $23,436.00, is for the provision of the ACP MAX PRP SYSTEM (OUS/EU) medical product. The contract is a Fixed Price with Economic Price Adjustment type, and has an ultimate completion date of January 22, 2025. Arthrex Inc., a for-profit Subchapter S Corporation, is the prime...
This federal contract award, valued at $1,409.76, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the delivery of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized medical device used in orthopedic procedures. The contract is a Delivery Order with a Fixed Price and Economic Price Adjustment pricing type, and has an ultimate completion date of March 18, 2025. Arthrex Inc. is...